What is TriMed?
TriMed Incorporated operates at the intersection of advanced engineering and clinical orthopedics, specializing in the design and manufacture of upper and lower extremity implants. The company has established a robust market position through its comprehensive portfolio of fixation systems, plates, screws, and specialized surgical instrumentation. By focusing on the complexities of periarticular fractures and the refinement of open reduction and internal fixation (ORIF) techniques, TriMed provides essential tools that enable surgeons to achieve superior patient outcomes. Their commitment to versatility and reliability has made them a preferred partner for healthcare institutions seeking to modernize their orthopedic surgical capabilities.
How much funding has TriMed raised?
TriMed has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in TriMed
PPP
Public-Private Partnership
What's next for TriMed?
With this latest infusion of capital, TriMed is well-positioned to accelerate its research and development pipeline, focusing on the next generation of orthopedic fixation technology. The company is expected to leverage these resources to expand its global distribution footprint and enhance its surgical training programs for healthcare professionals. As the orthopedic market continues to demand more precise and minimally invasive solutions, TriMed's strategic focus on innovation will likely drive further growth and market penetration. The firm remains dedicated to maintaining its leadership in the treatment of complex fractures, ensuring that its product ecosystem evolves in tandem with the changing needs of the global surgical community.
See full TriMed company page
